ID: ALA4590357

Max Phase: Preclinical

Molecular Formula: C20H20N4O

Molecular Weight: 332.41

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCn1cc2c(n1)C(=O)N(C)Cc1ccc(-c3cccnc3C)cc1-2

Standard InChI:  InChI=1S/C20H20N4O/c1-4-24-12-18-17-10-14(16-6-5-9-21-13(16)2)7-8-15(17)11-23(3)20(25)19(18)22-24/h5-10,12H,4,11H2,1-3H3

Standard InChI Key:  CXGMELZHEJKZMF-UHFFFAOYSA-N

Associated Targets(Human)

Metabotropic glutamate receptor 3 732 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 332.41Molecular Weight (Monoisotopic): 332.1637AlogP: 3.53#Rotatable Bonds: 2
Polar Surface Area: 51.02Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.50CX LogP: 2.40CX LogD: 2.40
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: -0.70

References

1. Kargbo RB..  (2019)  Allosteric mGluR3 Modulators for the Treatment of Psychiatric Disorders.,  10  (2): [PMID:30783491] [10.1021/acsmedchemlett.8b00619]

Source